NCT05767866 2023-03-17Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFRSuzhou Puhe Pharmaceutical Technology Co., LTDPhase 1/2 Unknown160 enrolled